Glenmark Pharma Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Glenmark Pharma Quarterly Results    (GLPH)

Here are the latest quarterly results of Glenmark Pharma. For more details, see the Glenmark Pharma financial fact sheet and Glenmark Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Glenmark Pharma Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-17
*
3
Dec-17
*
3
Mar-18
*
3
Jun-18
*
3
Sep-18
*
3
Dec-18
*
3
Mar-19
*
3
Jun-19
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m22,56622,03722,79821,65625,81325,55025,63523,229 
Other income Rs m297-2326961,3821,399-1,09039117 
Turnover Rs m22,86321,80523,49423,03827,21224,46026,02523,245 
Expenses Rs m18,68218,81019,53018,18721,41221,20421,99319,810 
Gross profit Rs m3,8843,2273,2683,4696,0734,3473,6413,419 
Depreciation Rs m752754735794825831810907 
Interest Rs m698705744790851885819930 
Profit before tax Rs m2,7311,5372,4853,2675,7961,5402,4031,598 
Tax Rs m5894899689371,656377786506 
Profit after tax Rs m2,1411,0471,5162,3304,1401,1631,6171,093 
Gross profit margin %17.214.614.316.023.517.014.214.7 
Effective tax rate %21.631.839.028.728.624.532.731.6 
Net profit margin %9.54.86.710.816.04.66.34.7 
Diluted EPS Rs 7.6 3.7 5.4 8.3 14.7 4.1 5.7 3.9  
Diluted EPS (TTM) Rs 42.1 28.9 28.5 24.9 32.0 32.4 32.8 28.4  
 Subscriber Feature View                
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Glenmark Pharma 1QFY20 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   INDRAPRASTHA MEDICAL  FRESENIUS KABI ONCO.  AUROBINDO PHARMA  NOVARTIS  FDC LTD.  

Compare GLENMARK PHARMA With:   INDRAPRASTHA MEDICAL  FRESENIUS KABI ONCO.  AUROBINDO PHARMA  NOVARTIS  FDC LTD.  

Compare GLENMARK PHARMA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 71 Points Lower; Telecom and Metal Stocks Witness Selling(Closing)

Indian share markets traded on a volatile note throughout the day and ended marginally lower. Benchmark indices gave up gains after the central bank kept its policy rate unchanged.

Views on news

GLENMARK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of GLENMARK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.

GLENMARK PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 53.1% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, GLENMARK PHARMA has posted a net profit of Rs 1 bn (down 53.1% YoY). Sales on the other hand came in at Rs 23 bn (up 7.3% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 6.6% (Quarterly Result Update)

Jun 3, 2019 | Updated on Jun 3, 2019

For the quarter ended March 2019, GLENMARK PHARMA has posted a net profit of Rs 2 bn (up 6.6% YoY). Sales on the other hand came in at Rs 26 bn (up 12.4% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of GLENMARK PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Could this Smallcap Be the Next Page Industries? (Profit Hunter)

Nov 27, 2019

A single stock - Coca Cola, made Buffett billions. Here's your chance to break into the crorepati club with a single smallcap stock investment.

My Best Trading Recommendation of the Year

Nov 22, 2019

My short-term views on the two assets, I'm most bullish on.

How We Made 12.68% in One Overnight Trade (The 5 Minute Wrapup)

Nov 25, 2019

This one trade had my subscribers laughing all the way to the bank.

How to Take Out Money from the Trading Terminal and Put it in to Your Pocket (Profit Hunter)

Nov 22, 2019

Here's a simple way to move money out of your trading terminal and into your pocket.

Two Trends to Look at as Sensex Crosses 41,000 Levels Views On News (Views On News)

Nov 26, 2019

The two trends that are playing out as Sensex touches new record high.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

GLENMARK PHARMA SHARE PRICE


Dec 5, 2019 (Close)

TRACK GLENMARK PHARMA

  • Track your investment in GLENMARK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GLENMARK PHARMA

GLENMARK PHARMA - ACTAVIS COMPARISON

COMPARE GLENMARK PHARMA WITH

MARKET STATS